Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Gastric cancer suppression  





2 miR-155 upregulation and other molecular targets  





3 See also  





4 References  





5 Further reading  





6 External links  














Mir-663 microRNA precursor family






ி
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


mir-663
Identifiers
Symbolmir-663
RfamRF00957
miRBase familyMIPF0000462
Other data
RNA typemicroRNA
Domain(s)Eukaryota;
PDB structuresPDBe

Inmolecular biology mir-663 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by several mechanisms.

Gastric cancer suppression

[edit]

miR-663 has been identified as a possible suppressor of tumour growth, with its levels downregulated in human gastric cancer cell lines. Its introduction into the two human gastric cancer cell lines BGC823 and SNU5 induces morphology changes and suppresses cell proliferation.[1] Transfection with miR-663 also sees a resultant upregulation of cyclin B.

miR-155 upregulation and other molecular targets

[edit]

Resveratrol, a natural phenol and antioxidant, upregulates miR-663 in human THP-1 monocytic cells, human blood monocytes and MCF7 brest cancer cells.[2] Endogenous activator protein-1 (AP-1) activity is decreased by miR-663 and there is additional impaired lipopolysaccharide upregulation. miR-663 directly targets JunD and JunB transcripts, and alters AP-1 upregulation through this. It is further involved in the impaired lipopolysaccharide upregulation of miR-155 by resveratrol.[3] miR-663 also directly targets EEF1A2, translation elongation factor and well-known protooncogene.[2][4]

See also

[edit]

References

[edit]
  1. ^ Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z, Ran Y (July 2010). "Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells". Oncology Reports. 24 (1): 105–12. doi:10.3892/or_00000834. PMID 20514450.
  • ^ a b Vislovukh A, Kratassiouk G, Porto E, Gralievska N, Beldiman C, Pinna G, El'skaya A, Harel-Bellan A, Negrutskii B, Groisman I (June 2013). "Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744". British Journal of Cancer. 108 (11): 2304–11. doi:10.1038/bjc.2013.243. PMC 3681015. PMID 23695020.
  • ^ Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM (September 2010). "Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD". Carcinogenesis. 31 (9): 1561–6. doi:10.1093/carcin/bgq143. PMC 4647642. PMID 20622002.
  • ^ Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM (July 2002). "Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer". Nature Genetics. 31 (3): 301–5. doi:10.1038/ng904. PMID 12053177. S2CID 37997742.
  • Further reading

    [edit]
    • Liang P, Lv C, Jiang B, Long X, Zhang P, Zhang M, Xie T, Huang X (June 2012). "MicroRNA profiling in denatured dermis of deep burn patients". Burns. 38 (4): 534–40. doi:10.1016/j.burns.2011.10.014. PMID 22360957.
  • Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Wang G, Li PK, Szeto CC (May 2012). "Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis". Nephrology. 17 (4): 346–51. doi:10.1111/j.1440-1797.2012.01573.x. PMID 22295894. S2CID 24163790.
  • Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP (October 2012). "MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma". Oncogene. 31 (41): 4421–33. doi:10.1038/onc.2011.629. PMID 22249270.
  • Yang Y, Wang LL, Li YH, Gao XN, Liu Y, Yu L (February 2012). "Effect of CpG island methylation on microRNA expression in the k-562 cell line". Biochemical Genetics. 50 (1–2): 122–34. doi:10.1007/s10528-011-9478-9. PMID 22089542. S2CID 16736093.
  • Marques FZ, Campain AE, Tomaszewski M, Zukowska-Szczechowska E, Yang YH, Charchar FJ, Morris BJ (December 2011). "Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs". Hypertension. 58 (6): 1093–8. doi:10.1161/HYPERTENSIONAHA.111.180729. PMID 22042811.
  • Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (December 2011). "Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue". Molecular Oncology. 5 (6): 564–76. doi:10.1016/j.molonc.2011.08.004. PMC 5528325. PMID 21917534.
  • Tili E, Michaille JJ (2011). "Resveratrol, MicroRNAs, Inflammation, and Cancer". Journal of Nucleic Acids. 2011: 102431. doi:10.4061/2011/102431. PMC 3154569. PMID 21845215.
  • Yang Y, Wang LL, Li YH, Gao XN, Yu L (April 2011). "[Expression level of miRNA-663 in different leukemic cell lines and its biological function]". Zhongguo Shi Yan Xue Ye Xue Za Zhi. 19 (2): 279–83. PMID 21518471.
  • Jian P, Li ZW, Fang TY, Jian W, Zhuan Z, Mei LX, Yan WS, Jian N (April 2011). "Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663". Journal of Hematology & Oncology. 4: 20. doi:10.1186/1756-8722-4-20. PMC 3094392. PMID 21518431.
  • Ni CW, Qiu H, Jo H (May 2011). "MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells". American Journal of Physiology. Heart and Circulatory Physiology. 300 (5): H1762-9. doi:10.1152/ajpheart.00829.2010. PMC 3094086. PMID 21378144.
  • Potapova A, Albat C, Hasemeier B, Haeussler K, Lamprecht S, Suerbaum S, Kreipe H, Lehmann U (January 2011). "Systematic cross-validation of 454 sequencing and pyrosequencing for the exact quantification of DNA methylation patterns with single CpG resolution". BMC Biotechnology. 11: 6. doi:10.1186/1472-6750-11-6. PMC 3032674. PMID 21235780.
  • Liu ZY, Zhang GL, Wang MM, Xiong YN, Cui HQ (2011). "MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation". Asian Pacific Journal of Cancer Prevention. 12 (11): 2819–23. PMID 22393947.
  • Dreher A, Rossing M, Kaczkowski B, Nielsen FC, Norrild B (December 2010). "Differential expression of cellular microRNAs in HPV-11 transfected cells. An analysis by three different array platforms and qRT-PCR". Biochemical and Biophysical Research Communications. 403 (3–4): 357–62. doi:10.1016/j.bbrc.2010.11.035. PMID 21078297.
  • Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N, Croce CM (December 2010). "Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells". Biochemical Pharmacology. 80 (12): 2057–65. doi:10.1016/j.bcp.2010.07.003. PMC 3918904. PMID 20637737.
  • Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM (September 2010). "Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD". Carcinogenesis. 31 (9): 1561–6. doi:10.1093/carcin/bgq143. PMC 4647642. PMID 20622002.
  • Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe M, Abdelmohsen K (June 2010). "MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence". Aging. 2 (6): 333–43. doi:10.18632/aging.100159. PMC 2919253. PMID 20606251.
  • Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA, Bruner GR, Harley JB, Ojwang JO (May 2010). Means T (ed.). "Identification of unique microRNA signature associated with lupus nephritis". PLOS ONE. 5 (5): e10344. Bibcode:2010PLoSO...510344T. doi:10.1371/journal.pone.0010344. PMC 2867940. PMID 20485490.
  • Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F (May 2010). "Nuclear factor TDP-43 can affect selected microRNA levels". The FEBS Journal. 277 (10): 2268–81. doi:10.1111/j.1742-4658.2010.07643.x. PMID 20423455.
  • Maes OC, Sarojini H, Wang E (October 2009). "Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts". Journal of Cellular Physiology. 221 (1): 109–19. doi:10.1002/jcp.21834. PMID 19475566. S2CID 21566082.
  • Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, Dianzani MU, Negrini M, Barrera G (January 2009). "MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation". Free Radical Biology & Medicine. 46 (2): 282–8. doi:10.1016/j.freeradbiomed.2008.10.035. PMID 19022373.
  • Lehmann U, Hasemeier B, Römermann D, Müller M, Länger F, Kreipe H (2007). "[Epigenetic inactivation of microRNA genes in mammary carcinoma]". Verhandlungen der Deutschen Gesellschaft für Pathologie. 91: 214–20. PMID 18314617.
  • Lehmann U, Hasemeier B, Christgen M, Müller M, Römermann D, Länger F, Kreipe H (January 2008). "Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer". The Journal of Pathology. 214 (1): 17–24. doi:10.1002/path.2251. PMID 17948228. S2CID 22024957.
  • [edit]
    Retrieved from "https://en.wikipedia.org/w/index.php?title=Mir-663_microRNA_precursor_family&oldid=1174531690"

    Categories: 
    Rfam pages needing a picture
    MicroRNA
    MicroRNA precursor families
     



    This page was last edited on 9 September 2023, at 01:42 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki